| 10/18 8:30 am - 11:00 am. Roundtable & Networking: "Lab Decontamination & Chemical Moves." Sponsored by Triumvirate Environmental. Crowne Plaza, Hartford, CT. more |
| 10/24 3:00 pm - 6:00 pm. CURE and Yale OCR Present: BioRelix. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. CT. more |
| 11/13 3:30 pm - 6:00 pm. CURE and Yale OCR Present: Vascular Insights LLC. A BioHaven Entrepreneurship Seminar. Reception and networking to follow. Anlyan Center, Congress Avenue, New Haven, CT. Watch for details. |
| 12/4 4:00 pm - 5:00 pm. CURE Annual Meeting. Achillion Conference Room, 300 George Street, New Haven, CT. Watch for details. |
| 12/4 5:30 pm - 7:30 pm. CURE Holiday Party. Location TBD. "New Haven's best holiday networking event." Watch for details. |
| 2/20 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Rib-X. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
| 3/19 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
| 3/26 Connecticut Innovations Annual Technology Celebration. The Aqua Turf Club, Southington, CT. more |
| 4/16 3:30 pm - 6:00 pm. CURE and Yale OCR Present: The Next Big Idea - Creating a New Venture. A Special BioHaven Entrepreneurship Panel with Roger Longman of Windhover Publications. Reception and networking to follow. Anlyan Center, Congress Avenue, New Haven, CT. Watch for details. |
| 4/23 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
|  |
|
|
BioBus Hostage to Bond Package Impasse
From the desk of Paul Pescatello, President and CEO of CURE
 With the adoption of a core science curriculum by the state, the moment is at hand to substantially expand the depth and reach of CURE’s popular BioBus Educational Programs. With that in mind, the BioBus staff has put together exciting plans to develop regional service centers throughout the state and has upgraded its curriculum and professional development initiatives. Unfortunately, these enhancements are now in jeopardy because the state bond package, for the second year in a row, is stalled due to General Assembly-Gubernatorial disagreement.
For the full story
|
Pfizer Names Martin McKay to Top R&D Position
Pfizer on Oct 4 named Dr. Martin Mackay president of Pfizer Global Research and Development (PGRD); launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Dr. Corey Goodman; and named Dr. Briggs Morrison, who held senior research and development positions at Merck, as its new head of clinical development for the PGRD pipeline.
For the full story
|
CURE Tells Industry Story with Congressman Chris Murphy and at Quinnipiac University
Two high-profile meetings last month gave CURE a platform for telling the pharma/biotech story. The events, held Sept 24 in Waterbury and Hamden, included a discussion of the industry’s bright future combined with a cautionary tale of the market and regulatory forces that could limit the its ability, over time, to discover and develop new lifesaving medicines.
For the full story
|
Tech Transfer for the Rest of Us
Technology transfer has become a dynamic force at major research universities – but how can smaller schools tap into this trend? Enter Ben Muskin, whose new consulting business helps schools with smaller research budgets get the most out of their intellectual assets.
For the full story
|
BioRelix Opens New Yale BioHaven Series
Presented by CURE and Yale OCR, the Yale BioHaven Entrepreneuship Series opens a new season this Oct 24 at the Anlyan Center with a presentation by BioRelix, a Yale spin-out developing antibiotics that target microbial RNA. Founder Ronald Breaker, Ph.D., and interim CEO Ronald Lennox, D. Phil., will present.
For the full story
|
BioBus and BioConnection Visits Scheduled
 Sixty-five schools from across Connecticut will challenge their students with advanced life science experiments this academic year. Twenty-six of the schools will host the BioBus, Connecticut's one-of-a-kind mobile laboratory on wheels. Others will use similar equipment on loan through BioConnection.
For the full story
|
CURE Member News Digest
 454 Life Sciences finds honeybee virus
Achillion appoints David Wright to board
Alexion reports clot reduction following Soliris™ treatments
Bayer HealthCare reports start of Phase III MS trials
Boehringer Ingelheim adds to Ridgefield campus
Bristol-Myers Squibb to acquire Adnexus Therapeutics
Cara Therapeutics builds out with $4 million from CI
Connecticut Innovations seeds New Ortho Polymers
CuraGen names Timothy Shannon president and CEO
GlaxoSmithKline reports Avodart® studies
Hartford Hospital appoints Detlef Wencker to Heart Center
HistoRx to provide AQUA® technolgy to NCI-funded group
Invitrogen awarded summer olympics contract
Ipsogen signs agreement with XENOMICS
Johnson & Johnson reports Phase III interleukin results
NanoViricides sees drug filing in two years
Neurogen names Stephen Davis president
Optherion lease Long Wharf space
Pfizer says British study backs Lipitor
PhRMA testifies on counterfeit drug problem
Praxair named to Dow Jones index
Protein Sciences Corporation (Meriden) licenses FluBlØk
Vion Pharmaceuticals to test Cloretazine® on gliomas
Dr. Laura Grabel of Wesleyan University interviewed by WNPR
UConn Health Center finds key to vision loss
Yale offers new view of genetic variability
For the full story
|
|
|
